Skip to main content

Publisher: Wolters Kluwer

Volume 31, Number 3, 1 May 2015

Editorial introductions
pp. v-vi(2)
Authors: Rockey, Don C.; Gores, Gregory J.

Favourites:
ADD

Advances in hepatology: 2015
pp. 173-174(2)
Author: Rockey, Don C.

Favourites:
ADD

Nonalcoholic fatty liver disease: new treatments
pp. 175-183(9)
Authors: Hardy, Timothy; Anstee, Quentin M.; Day, Christopher P.

Favourites:
ADD

Aging and liver disease
pp. 184-191(8)
Authors: Kim, In Hee; Kisseleva, Tatiana; Brenner, David A.

Favourites:
ADD
Favourites:
ADD

Noninvasive assessment of liver function
pp. 199-208(10)
Authors: Helmke, Steve; Colmenero, Jordi; Everson, Gregory T.

Favourites:
ADD

Current management of acute liver failure
pp. 209-214(6)
Authors: McPhail, Mark J.W.; Kriese, Stephen; Heneghan, Michael A.

Favourites:
ADD

Renal dysfunction in cirrhosis
pp. 215-223(9)
Authors: Urrunaga, Nathalie H.; Mindikoglu, Ayse L.; Rockey, Don C.

Favourites:
ADD

Update on the management of the liver transplant patient
pp. 224-232(9)
Authors: Kwong, Allison J.; Fix, Oren K.

Favourites:
ADD
Favourites:
ADD

Biomarkers for disease progression of primary sclerosing cholangitis
pp. 239-246(8)
Authors: de Vries, Elisabeth M.G.; Beuers, Ulrich; Ponsioen, Cyriel Y.

Favourites:
ADD

Immunoglobulin G4-related cholangiopathy: clinical and experimental insights
pp. 252-257(6)
Authors: Maillette de Buy Wenniger, Lucas J.; Beuers, Ulrich

Favourites:
ADD

Genetics of Opisthorchis viverrini-related cholangiocarcinoma
pp. 258-263(6)
Authors: Jusakul, Apinya; Kongpetch, Sarinya; Teh, Bin Tean

Favourites:
ADD

Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma
pp. 264-268(5)
Authors: Borad, Mitesh J.; Gores, Gregory J.; Roberts, Lewis R.

Favourites:
ADD

Gallbladder cancer in Chile: what have we learned?
pp. 269-275(7)
Authors: Roa, Iván; de Aretxabala, Xabier

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content